24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
EpiPen
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:47
Israeli startups raise over $1.25 billion in April, lifted by Vast Data’s mega-round
21:15
Minimus: "Today the most meaningful benefit is trust and flexibility"
19:43
Kela raising $200 million at $1 billion valuation with backing from Bill Ackman and Eric Schmidt
16:00
CopilotKit raises $27 million to build infrastructure for AI agents
More stories
Buzz
Most popular
Daily
Weekly
1
Cisco acquires AI security startup Astrix for $400 million
2
Five bidders advance in Nice’s $2.5 billion Actimize sale process
3
The 50 most promising Israeli startups - 2026
4
Israeli tech veterans launch $100 million AI and cyber fund
5
Kela raising $200 million at $1 billion valuation with backing from Bill Ackman and Eric Schmidt
More news
EpiPen
4 stories about EpiPen
Teva Jumps on NYSE on a Bit of Good News
21.08.19
|
Hezi Sternlicht
An opioid-abuse lawsuit settlement reached by drugmakers Endo and Allergan Tuesday could bode well for Teva’s legal future, as does the release of an FDA-approved generic version of EpiPen JR
Teva, Mylan Drop on Announcement of Epinephrine Injector Rival
09.12.18
|
Lilach Baumer
Novartis’ U.S. division Sandoz announced a planned release for early 2019. The company will sell its drug, which lacks the EpiPen’s auto-injector, for $250 a pair out of pocket, compared to Mylan and Teva’s $300
Teva’s Generic EpiPen Now Available in the U.S. in Limited Numbers
28.11.18
|
Lilach Baumer
In August, the Israel-headquartered drugmaker won approval to market the first generic EpiPen auto-injectors in the U.S.
Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says
26.08.18
|
Dror Reich
The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month